|
gptkbp:instance_of
|
gptkb:Company
gptkb:Insurance_Company
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Vinod_Khosla
gptkb:The_Inventor:_Out_for_Blood_in_Silicon_Valley
|
|
gptkbp:acquisition
|
gptkb:none
gptkb:battle
|
|
gptkbp:author
|
gptkb:John_Carreyrou
gptkb:Bad_Blood:_Secrets_and_Lies_in_a_Silicon_Valley_Startup
|
|
gptkbp:business_model
|
gptkb:Insurance_Company
gptkb:battle
retail partnerships
partnerships with pharmacies
blood testing services
direct-to-consumer testing
|
|
gptkbp:ceo
|
gptkb:Elizabeth_Holmes
gptkb:2021
gptkb:Sunny_Balwani
January 2022
Stanford dropout
former intern at Genentech
|
|
gptkbp:clinical_trial
|
guilty verdict
|
|
gptkbp:closing_date
|
gptkb:2018
|
|
gptkbp:controversy
|
fraud allegations
|
|
gptkbp:court
|
gptkb:2019
|
|
gptkbp:discontinued
|
gptkb:2018
gptkb:theorem
|
|
gptkbp:dissolved
|
gptkb:2018
|
|
gptkbp:documentary
|
gptkb:The_Inventor:_Out_for_Blood_in_Silicon_Valley
|
|
gptkbp:economic_impact
|
regulatory changes
increased scrutiny of startups
increased scrutiny on startups
|
|
gptkbp:employees
|
over 800
approximately 800
|
|
gptkbp:end_date
|
January 2022
|
|
gptkbp:financial_performance
|
gptkb:2018
|
|
gptkbp:financial_products
|
gptkb:battle
|
|
gptkbp:first_published
|
gptkb:Bad_Blood:_Secrets_and_Lies_in_a_Silicon_Valley_Startup
|
|
gptkbp:founded
|
gptkb:Elizabeth_Holmes
gptkb:2003
|
|
gptkbp:founder
|
gptkb:Ramesh_Balwani
gptkb:Elizabeth_Holmes
gptkb:Sunny_Balwani
|
|
gptkbp:headcount
|
approximately 800
|
|
gptkbp:headquarters
|
gptkb:California
gptkb:Palo_Alto
gptkb:Palo_Alto,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Theranos
|
|
gptkbp:industry
|
healthcare
|
|
gptkbp:inspiration
|
Silicon Valley entrepreneurs
|
|
gptkbp:investment
|
gptkb:Sergey_Brin
gptkb:Marc_Andreessen
gptkb:George_Shultz
gptkb:Ariana_Huffington
gptkb:David_Boies
gptkb:Henry_Kissinger
gptkb:Sheryl_Sandberg
gptkb:Larry_Page
gptkb:Larry_Ellison
gptkb:Tim_Cook
gptkb:Jack_Dorsey
gptkb:Richard_Branson
gptkb:John_Doerr
gptkb:Peter_Thiel
gptkb:David_Sacks
gptkb:Betsy_De_Vos
gptkb:Jeffrey_Katzenberg
gptkb:Tim_Draper
gptkb:Settlement
gptkb:Alyssa_Jayne_Milano
gptkb:Maxim_Levchin
gptkb:Rupert_Murdoch
gptkb:James_Norman_Mattis
lawsuits
diminished
$700 million
Ravi Gupta
Don Lucas
high accuracy tests
low cost tests
|
|
gptkbp:is_valued_for
|
9 billion USD
$9 billion (peak)
|
|
gptkbp:launch_date
|
August 2021
|
|
gptkbp:legacy
|
cautionary tale
impact on healthcare startups
impact on venture capital
|
|
gptkbp:legal_issue
|
fraud charges
|
|
gptkbp:losses
|
hundreds of millions USD
|
|
gptkbp:market
|
gptkb:2014
|
|
gptkbp:media
|
gptkb:newspaper
public outrage
|
|
gptkbp:media_coverage
|
extensive
|
|
gptkbp:members
|
gptkb:Ramesh_Balwani
gptkb:David_Boies
gptkb:Henry_Kissinger
gptkb:William_H._Foege
gptkb:James_Norman_Mattis
|
|
gptkbp:notable_products
|
gptkb:Edison_device
|
|
gptkbp:outcome
|
gptkb:United_States_v._Elizabeth_Holmes
gptkb:United_States_v._Ramesh_Balwani
appeal process
guilty verdicts
guilty on four counts
pending appeals
hung jury on three counts
not guilty on four counts
awaiting sentencing
|
|
gptkbp:partnership
|
gptkb:Company
gptkb:Cleveland_Clinic
gptkb:Safeway
|
|
gptkbp:partnerships
|
gptkb:University_of_California,_Merced
gptkb:University_of_Illinois
gptkb:University_of_North_Carolina_at_Chapel_Hill
gptkb:University_of_California,_Santa_Cruz
gptkb:University
gptkb:Company
gptkb:Duke_University
gptkb:Johns_Hopkins_University
gptkb:Stanford_University
gptkb:University_of_California,_Irvine
gptkb:University_of_California,_Los_Angeles
gptkb:University_of_California,_San_Francisco
gptkb:University_of_Chicago
gptkb:University_of_Michigan
gptkb:University_of_Pennsylvania
gptkb:University_of_Washington
gptkb:Thermo_Fisher_Scientific
gptkb:University_of_California,_Davis
gptkb:University_of_California,_San_Diego
gptkb:University_of_Texas_at_Austin
gptkb:University_of_California,_Riverside
gptkb:Arizona_State_University
gptkb:Cleveland_Clinic
gptkb:University_of_California,_Santa_Barbara
gptkb:University_of_Florida
gptkb:Safeway
crisis management
|
|
gptkbp:production_company
|
defunct
bankrupt
|
|
gptkbp:products
|
gptkb:Edison_device
mini Lab
|
|
gptkbp:public_perception
|
negative
deceptive practices
|
|
gptkbp:regulatory_compliance
|
gptkb:FDA
gptkb:CMS
FDA scrutiny
CMS sanctions
|
|
gptkbp:release_year
|
gptkb:2019
|
|
gptkbp:research
|
unproven technology
|
|
gptkbp:revenue
|
gptkb:unknown
none reported
$100 million (peak)
|
|
gptkbp:technology
|
gptkb:Edison_device
blood testing
fingerstick blood samples
revolutionary blood tests
|
|
gptkbp:year
|
gptkb:2018
|
|
gptkbp:year_created
|
gptkb:2003
|